Skip to main content

CPDA-1

Generic: Anticoagulant Citrate Phosphate Dextrose Adenine

Verified·Apr 23, 2026
Manufacturer
Fresenius Kabi
NDC
0942-6305
Route
INTRAVENOUS
ICD-10 indication
R69

Affordability Check

How much will you actually pay for CPDA-1?

In 30 seconds, see every legitimate way to afford CPDA-1 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About CPDA-1

What is this medication? CPDA-1 is an anticoagulant and preservative solution used primarily during the collection and storage of whole blood or red blood cells. It consists of a specific combination of citrate, phosphate, dextrose, and adenine. The citrate works to prevent the blood from clotting by binding with calcium ions, while the phosphate acts as a buffer to maintain a stable pH balance throughout the duration of storage.

Dextrose is included in the mixture to provide a necessary energy source for the red blood cells to sustain their metabolic functions while outside the body. The addition of adenine is a key feature that helps cells maintain levels of adenosine triphosphate, or ATP, which significantly extends the viable shelf life of the collected blood. When this solution is used, stored blood components can typically remain suitable for transfusion for up to thirty-five days under proper refrigeration.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.